Revelation Biosciences
REVB · NASDAQ
$3.75+$3.28 (+699.06%)TodayMarket closed ·
Prev close $0.4693
Who owns REVB
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 20.1% of REVB’s shares.
- Rolke (James M)7.8%
- Sabby Management, LLC5.4%
- Zygmont (Chester Stanley III)1.9%
- Citadel Advisors LLC1.0%
- Next 6 largest institutions4.0%
- All other shareholders79.9%
| Holder | Shares | % of shares |
|---|---|---|
| Rolke (James M) | 306.26K | 7.83% |
| Sabby Management, LLC | 210.58K | 5.39% |
| Zygmont (Chester Stanley III) | 74.97K | 1.92% |
| Citadel Advisors LLC | 38.58K | 0.99% |
| Roper (Jess) | 36.97K | 0.95% |
| Carver (Jennifer A) | 36.90K | 0.94% |
| Chawla (Lakhmir S) | 36.30K | 0.93% |
| Geode Capital Management, L.L.C. | 17.19K | 0.44% |
| HRT Financial LP | 16.98K | 0.43% |
| Vanguard Fiduciary Trust Co | 13.13K | 0.34% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Fidelity Extended Market Index Fund | 16.64K | 0.43% |
| Blackstone Alternative Multi-Strategy Fund | 50 | 0.00% |
Insider trades
Form 4 filings by officers, directors and large holders
Insiders made no open-market buys or sales of REVB in the last 6 months.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Zygmont Chester Stanley III | Gift | 208.07K | — |
| Zygmont Chester Stanley III | Gift | 208.07K | — |
| Zygmont Chester Stanley III | Award | 208.07K | — |
| Rolke James | Award | 208.08K | — |
| CARVER JENNIFER | Award | 32.01K | — |
| Chawla Lakhmir S | Award | 32.01K | — |
| ROPER JESS | Award | 32.01K | — |
| Zygmont Chester Stanley III | Tax withholding | 13.29K | $14.61K |
| Rolke James | Tax withholding | 10.12K | $11.43K |
Short interest
Settled Sep 30, 2026
- Shares short
- 1.58K
- Days to cover
- 1.00
- % of shares outstanding
- 0.04%
- Average daily volume
- 36.22K
- Change since last report
- +517.6%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.